A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Garcia-Casado, Zaida
- Pajuelo, Juan C.
- Bolufer, Pascual
Abstract
Acute promyelocytic leukemia (APL) is genetically characterized by a reciprocal translocation between chromosomes 15 and 17, the t(15;17)(q22;q21), which results in the fusion gene PML/RARA. A small proportion of patients with APL have complex or simple variants of this translocation. We report the case of a 31-year-old woman with APL (FAB-M3 classical form) carrying an apparently balanced translocation t(17;20)(q21;q12) masking a t(15;17)(q22;q21) confirmed by fluorescence in situ hybridization (FISH) and molecular studies. The patient was treated with an all-trans-retinoic acid (ATRA) plus anthracycline-based protocol and achieved complete remission, with no recurrence to date. These results illustrate the usefulness of combining cytogenetics. FISH. and reverse transcription-polymerase chain reaction (RT-PCR) methods to evidence the PML/RARA fusion gene in cases with morphologic suspicion of APL with variant or cryptic t(15;17). (c) 2006 Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0165-4608, 1873-4456
- Tipo:
- Article
- Páginas:
- 73-76
- PubMed:
- 16772124
- Factor de Impacto:
- 0,777 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
CANCER GENETICS AND CYTOGENETICS ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 7
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- TRANSLOCATION; PETHEMA; RISK
Proyectos y Estudios Clínicos
RED DE INVESTIGACION COOPERATIVA DE CANCER
RD06/0020/0031 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006
Cita
Garcia Z,CERVERA J,VALENCIA A,Pajuelo JC,MENA AV,BARRAGAN E,Bolufer P,SANZ MA. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia. Cancer Genet Cytogenet. 2006. 168. (1):p. 73-76. IF:1,000. (3).